As they gain popularity, weight loss medication will be the focus of a Spokane talk by obesity expert Dr. Ellen Schur.
Eli Lilly and Company (NYSE: LLY) today announced detailed results from the TOGETHER-PsA open-label Phase 3b clinical trial ...
Humans have long dreamed of a cure-all.Subscribe to The Post Most newsletter for the most important and interesting stories ...
Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in ...
A sweeping review of decades of research is challenging a long-standing claim in food policy debates: that federal nutrition assistance programs contribute to childhood obesity. Researchers at the ...
More and more women are having babies later in life. A federal report showed that 21% of all births in the U.S. were to women 35 and older in 2023, up from 8.8% in 1990. And this so-called ...
GLP-1-class weight-loss drugs can help users shed dozens of pounds, leading to a more active, energized life. One in eight ...
New federal dietary guidance includes advice on boosting testosterone levels, which clinicians say is only partially rooted in evidence.
BMI is just B.S. It doesn’t accurately define what it means to be overweight.
Everyday Health on MSN
New Kind of Diabetes Drug Helped People Lower Blood Sugar and Lose Almost 40 Pounds
The first-in-class injectable could be the next big thing in diabetes and obesity treatment.
The American Heart Association just released new guidance on dietary priorities for heart health. Learn what they say about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results